NYSE · ANRO
Alto Neuroscience, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ANRO: Nov 11, 2026
Alto Neuroscience, Inc. Common Stock is estimated to report earnings on 11/11/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.6. The reported EPS for the same quarter last year was $-0.52.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.60 | $-0.49 | $-0.68 | 6 |
| Dec 2026 | $-0.65 | $-0.51 | $-0.84 | 5 |
| Mar 2027 | $-0.67 | $-0.62 | $-0.76 | 3 |
| Jun 2027 | $-0.69 | $-0.61 | $-0.79 | 3 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · Barchart · Fintel- Zacks · Oct 14, 8:59 AM EDTHere's Why You Should Add ANRO Stock to Your Portfolio NowAlto advances its depression drug pipeline, with key 2027 study results ahead for ALTO-207, ALTO-300 and ALTO-100.
- Zacks · Oct 13, 8:40 AM EDTAre Medical Stocks Lagging Cardinal Health (CAH) This Year?Here is how Cardinal Health (CAH) and Alto Neuroscience, Inc. (ANRO) have performed compared to their sector so far this year.
- RTTNews · Aug 13, 4:28 AM EDTBiotech Stocks At 52-Week Highs – BIVI +22%, XNCR, ANRO, HAE, ACAD(RTTNews) – The following biotech stocks reached a 52-week high on August 12, 2026, driven up by key catalysts such as positive quarterly reports or promising results from clinical trials.
- RTTNews · Aug 7, 6:30 AM EDTBiotech Stocks At 52-Week Highs – DCTH +22% On Q2 Results, ANRO, COAG, MNPR, NRIX(RTTNews) – The following biotech stocks reached 52-week highs on August 7, 2026, driven by key catalysts such as positive quarterly reports or upcoming conference participation.
- RTTNews · Jul 15, 6:19 AM EDTAlto Prices Direct Offering Worth $100 Mln At $26.48 Per Share(RTTNews) – Alto Neuroscience Inc. (ANRO), a clinical-stage biopharmaceutical company, on Tuesday announced the pricing of an underwritten registered direct offering of the company's common shares.
- RTTNews · Jul 15, 3:50 AM EDTBiotech Stocks Hit 52-Week Highs – TOI, IKT, ANRO, ELV, PRVA(RTTNews) – These biotech stocks touched a 52-week high on July 14, 2026, attributable to key catalysts like announced offerings to increase capital and the expansion of business ventures.
- Barchart · Apr 6, 2:40 PM EDTStocks Recover on Hopes Strait of Hormuz Could Soon ReopenThe S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.11%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.11%. June E-mini S&P futures (ESM26 ) rose +0.08%, and June E-mini Nasdaq futures…
- Barchart · Apr 2, 7:42 PM EDTStocks Pare Losses on Hormuz ReportThe S&P 500 Index ($SPX ) (SPY ) today is down -0.06%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.20%. June E-mini S&P futures (ESM26 ) are down -0.04%, and June E-mini Nasdaq futures…
- Barchart · Apr 2, 6:30 PM EDTStocks Sink as President Trump Signals Iran War Will Drag OnThe S&P 500 Index ($SPX ) (SPY ) today is down -1.13%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -1.15%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.53%. June E-mini S&P futures (ESM26 ) are down -1.07%, and June E-mini Nasdaq futures…
- Fintel · Mar 27, 1:35 PM EDTAlto Neuroscience (ANRO) Price Target Increased by 15.20% to 36.72The average one-year price target for Alto Neuroscience (NYSE:ANRO) has been revised to $36.72 / share. This is an increase of 15.20% from the prior estimate of $31.88 dated February 21, 2026. The price target is an average of many targets provided by analysts
- RTTNews · Jan 27, 10:58 PM ESTTuesday After-Hours Session Sees Broad Gains Across Healthcare And Biotech(RTTNews) – Several healthcare and biotech stocks posted solid gains in Tuesday's after-hours session, with most moves occurring without company-specific news.
- Fintel · Nov 17, 7:03 AM ESTBTIG Initiates Coverage of Alto Neuroscience (ANRO) with Buy RecommendationFintel reports that on November 17, 2025, BTIG initiated coverage of Alto Neuroscience (NYSE:ANRO) with a Buy recommendation. Analyst Price Forecast Suggests 149.07% Upside
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Alto Neuroscience, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.